Cancer Treatment

Aaron Mitchell on use of ‘low-value’ cancer care in Medicare Advantage vs. Traditional Medicare

Clinically Significant Fatigue and Inflammation in Breast Cancer Survivors

Findings by Ali Weinstein, a scholar of chronic illness, indicate that quality of life may be impacted long after cancer treatment concludes.

Medicare Advantage less likely to use low-value cancer treatments, study finds

Mason researcher Marissa Howard leads a team of scientists who have discovered a way to “eavesdrop” on cellular communications that could revolutionize treatments for cancer and other maladies.

As her term as Chapter President concludes, Susan O. Koduah explains why collaboration was paramount to the success of her presidency.

George Mason University researchers are playing a role in the Cancer Moonshot Initiative designed to reduce cancer deaths

Study may provide opportunities to improve diet quality among cancer survivors